Retatrutide – 5mg / 10mg
Triple agonist peptide for advanced weight loss, glucose control, and metabolic health
Heather
Last Update há 7 meses
Category:
Weight Loss / Metabolic Health / Blood Sugar Control
Primary Benefits:
Promotes significant and sustained weight loss
Reduces appetite and food cravings
Improves blood sugar levels and insulin sensitivity
Supports cardiovascular and metabolic health
Mechanism of Action:
Retatrutide is a powerful triple agonist peptide that activates GLP-1, GIP, and glucagon receptors. This combination enhances insulin secretion, suppresses appetite, slows gastric emptying, and increases energy expenditure—making it one of the most promising multi-receptor therapies for obesity and metabolic syndrome.
Dosing & Protocol
Subcutaneous (SQ) Injection:
Reconstitution:
5 mg vial → 2.0 ml bacteriostatic water
10 mg vial → 2.0 ml bacteriostatic water
Weekly Dose:
5 mg vial → 1.0 mg (40 units)
10 mg vial → 1.0 mg (20 units)
Cycle:
Inject Once Weekly on Your Chosen Day (e.g. every Monday)
o 1mg once weekly for weeks 1 and 2
o 2mg once weekly for weeks 3 and 4
o After 4 weeks, may increase up to 4 mg per week, as needed
o Do not exceed 4 mg per week
Take on the same day and time each week for stable blood levels.
Timing:
Take the same day and time each week for stable blood levels
Potential Side Effects:
Nausea or vomiting (especially during dose escalation)
Temporary fatigue or headache
Mild digestive discomfort (bloating or constipation)
Risk of hypoglycemia when combined with other glucose-lowering drugs
Rare: injection site irritation
Common Stacks:
With Cagrilintide: for synergistic appetite suppression
With 5-Amino-1MQ: for enhanced metabolic and fat-burning support
With AOD-9604: for fat breakdown without muscle loss
Notes:
Start with the lowest effective dose to assess tolerance
Rotate injection sites weekly to minimize skin irritation
Monitor blood glucose if using with other insulin-sensitizing agents
Best used as part of a comprehensive diet and movement plan
Disclaimer:
The information provided in this article is for educational and informational purposes only and is not intended as medical advice. These statements have not been evaluated by the FDA or Health Canada. Peptides and other compounds discussed are intended for research purposes only and are not approved for human consumption unless prescribed by a licensed medical professional. Always consult your healthcare provider before starting any new protocol, supplement, or treatment.
